- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2018
- Public Summary Document (PSD) July 2018 PBAC Meeting - PDF
- Public Summary Document (PSD) July 2018 PBAC Meeting - Word
Ertugliflozin with sitagliptin; 2. ertugliflozin; 3. ertugliflozin + metformin; 4. sitagliptin; 5. sitagliptin + metformin – July 2018
Ertugliflozin with sitagliptin: Tablet containing 5 mg ertugliflozin with 100 mg sitagliptin (as pho
Last updated
26 October 2018
